Tissue Repair Gel in Venous Leg Ulcers in AU/US
Recruiting
Phase 3
Interventional Study
Venous Leg Ulcer
Venous Ulcer
Venous Stasis Ulcer
Venous Stasis
Wound Heal
Wound
Venous Insufficiency of Leg
Non-healing Wound
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Pivotal Trial
This treatment is in the last trial phase before FDA approval.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Trial phase
- Phase 3
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 312 (estimated)
- Sponsor
- TR Therapeutics · Industry
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this clinical trial is to learn if TR987 0.1% gel + Standard of Care works better than Standard of Care alone to treat Venous Leg Ulcers (VLUs). It will also provide additional information about the safety of drug TR987 0.1% gel.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Adults 18 years and older
* Venous insufficiency has been clinically diagnosed clinically and medically confirmed.
* Females who are neither pregnant nor breastfeeding and if of child-bearing potential are on an acceptable method of birth control.
* The Venous Ulcer should be …
Contacts
Anhthu Nguyen Vice President, Global Clinical Operations
(+61) 280 034 554
anhthu.nguyen@trtherapeutics.com
CONTACT